[go: up one dir, main page]

WO1999029330A8 - Composition and method for treating nonalcoholic steatohepatitis - Google Patents

Composition and method for treating nonalcoholic steatohepatitis

Info

Publication number
WO1999029330A8
WO1999029330A8 PCT/US1998/025701 US9825701W WO9929330A8 WO 1999029330 A8 WO1999029330 A8 WO 1999029330A8 US 9825701 W US9825701 W US 9825701W WO 9929330 A8 WO9929330 A8 WO 9929330A8
Authority
WO
WIPO (PCT)
Prior art keywords
nonalcoholic steatohepatitis
liver
steatohepatitis
compounds
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/025701
Other languages
French (fr)
Other versions
WO1999029330A1 (en
Inventor
David Fan
Houn Simon Hsia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viva America Marketing Inc
Original Assignee
Viva America Marketing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viva America Marketing Inc filed Critical Viva America Marketing Inc
Priority to AU17102/99A priority Critical patent/AU1710299A/en
Publication of WO1999029330A1 publication Critical patent/WO1999029330A1/en
Publication of WO1999029330A8 publication Critical patent/WO1999029330A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation and damage to the liver cells. Typically, steatohepatitis involves inflammation of the liver related to fat accumulation, and mimics alcoholic hepatitis but is observed in patients who seldom or never consume alcohol. Nonalcoholic steatohepatitis can lead to serious liver damage, and ultimately cirrhosis. The present invention provides methods and compositions useful for the treatment or alleviation of nonalcoholic steatohepatitis and the pharmaceutical formulations for their administration to a human. Specifically, compositions comprised of lecithin, antioxidants and vitamin B complex are administered parenterally, most preferably by oral administration. Specific therapeutic formulations include admixtures of these compounds and specific dosage formulations include daily oral administrations of these compounds in tablet or powder forms.
PCT/US1998/025701 1997-12-05 1998-12-04 Composition and method for treating nonalcoholic steatohepatitis Ceased WO1999029330A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17102/99A AU1710299A (en) 1997-12-05 1998-12-04 Composition and method for treating nonalcoholic steatohepatitis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6732397P 1997-12-05 1997-12-05
US60/067,323 1997-12-05

Publications (2)

Publication Number Publication Date
WO1999029330A1 WO1999029330A1 (en) 1999-06-17
WO1999029330A8 true WO1999029330A8 (en) 1999-09-10

Family

ID=22075227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/025701 Ceased WO1999029330A1 (en) 1997-12-05 1998-12-04 Composition and method for treating nonalcoholic steatohepatitis

Country Status (4)

Country Link
AU (1) AU1710299A (en)
MY (1) MY117168A (en)
TW (1) TW548105B (en)
WO (1) WO1999029330A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010763A1 (en) 2001-12-21 2003-06-21 Simone Claudio De NEW LACTIC BACTERIA STOCK AND EDIBLE COMPOSITIONS, DRUGS AND VETERINARY PRODUCTS THAT CONTAIN IT.
JPWO2011158769A1 (en) * 2010-06-17 2013-08-19 国立大学法人 千葉大学 Non-alcoholic steatohepatitis detection and / or differentiation marker, non-alcoholic steatohepatitis detection and / or differentiation method, and kit used therefor
EP2945701B1 (en) * 2013-01-18 2023-04-05 Cornell University Methods of treating diseases associated with high fat diet and vitamin a deficiency using retinoic acid receptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595982A (en) * 1994-03-31 1997-01-21 Harlmen Inc. Equine nutritional supplement

Also Published As

Publication number Publication date
WO1999029330A1 (en) 1999-06-17
AU1710299A (en) 1999-06-28
MY117168A (en) 2004-05-31
TW548105B (en) 2003-08-21

Similar Documents

Publication Publication Date Title
Takasuna et al. Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
HK1048771A1 (en) Low dose entecavir formulation and use
ATE522211T1 (en) STABILIZED FIBRATE MICROPARTICLES
PL364174A1 (en) Fibrate-statin combinations with reduced fed-fasted effects
JP2003206238A (en) Medicinal composition
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
WO2007021805A3 (en) Estrogen compositions and therapeutic methods of use thereof
EP2340839A1 (en) A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid
JP5514216B2 (en) Pharmaceutical composition for prophylaxis and treatment of inflammatory diseases containing ethyl acetate fraction of dried chow stone extract as active ingredient, and method for producing the fraction
IL132992A0 (en) Method and compositions for administering taxanes orally to human patients
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
PL354777A1 (en) Method and compositions for administering taxanes orally to human patients
DK1027053T3 (en) Method of preventing nephrotoxicity caused by cyclosporins or tacrolimuses
CA2242589A1 (en) Composition containing diosgenin
DE60031259D1 (en) NUTRIENTS FROM SOYBEAN PROTEIN
WO1999029330A8 (en) Composition and method for treating nonalcoholic steatohepatitis
NO974486L (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
CN106511161A (en) Traditional Chinese herbal medicine toothpaste with treatment effect on canker sore
CN101342223B (en) Jade butterfly beauty treatment speckle removing plaster and preparation method thereof
CN114432376B (en) Blood lipid regulating drug composition and preparation thereof
RU2002129298A (en) APPLICATION OF GALANTAMINE FOR THE TREATMENT OF PSYCHONEUROLOGICAL BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE
JP2005023008A (en) Internal liquid medicine composition containing vitamin b group
KR20030022500A (en) Composition of healthfood for skin-whitening
CA2403674A1 (en) The use of t3 for treating congestive heart failure
JP2007016053A (en) Antineoplastic agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN JP MX SG

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT KR)

AK Designated states

Kind code of ref document: C1

Designated state(s): AU CA CN JP KR MX SG

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 24/99 UNDER (81) ADD "KR"; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase